Clinical Trial Update: Lapatinib Resistance in Patients With Breast Cancer

View source ↗

Summary

The clinical trial investigating resistance to lapatinib in breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Breast Cancer | Status: WITHDRAWN